Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
Ophthalmologic aspects of chikungunya infection.
Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.
Dynamic impact of brief electrical nerve stimulation on the neural immune axis-polarization of macrophages toward a pro-repair phenotype in demyelinated peripheral nerve.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: No.
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset.
Autonomic dysfunction in multiple sclerosis is better detected by heart rate variability and is not correlated with central autonomic network damage.
Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
Conclusions: Calls to action for improving the life of MS patients and their families.
Resveratrol Defends Blood-brain Barrier Integrity in Experimental Autoimmune Encephalomyelitis Mice.
Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity.
Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis.
EP23.01: Postive postnatal outcome in pregnancy with neuromyelitis optica.
The experience of transitioning from relapsing remitting to secondary progressive multiple sclerosis: views of patients and health professionals.
Restriction spectrum imaging reveals decreased neurite density in patients with temporal lobe epilepsy.
Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Increased Sleep Depth in Developing Neural Networks: New Insights from Sleep Restriction in Children.
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
Acute Multiple Sclerosis Relapse.
Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Myeloid cells - targets of medication in multiple sclerosis.
Neural Stem Cell Transplantation and CNS Diseases.

Pages